NPSP NPS Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NPSP NPS Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CYBERKEN who wrote (13)	8/7/1997 12:50:00 PM
From: Area51	of 363

Does anyone know why this stock is lanquishing? lost 0.21 last quarter versus first call est of -0.25. Should still have $5.00 per share cash at the end of next year, so the business is only selling at $3.00 per share. I saw that Eli Lily got expedited review of their new osteoporosis drug (7/23/97). Maybe this is what is driving the stock down?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next